152981-31-2
152981-31-2
Chemical Structure
Inolimomab
- CAS No.: 152981-31-2
- Formula:N/A
- Molecular Weight:(145.34 kDa)
IUPAC Name: tert-butyl (1r,3r)-3-amino-3-(hydroxymethyl)cyclobutane-1-carboxylate
SMILES: [Inolimomab]
Biological Activity: Inolimomab is an anti-interleukin-2 receptor (IL-2R) α chain monoclonal antibody. Inolimomab improves the survival rate in the early research of treating acute graft-versus-host disease (aGVHD)[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Inolimomab | 98.78% | Inolimomab is an anti-interleukin-2 receptor (IL-2R) α chain monoclonal antibody. Inolimomab improves the survival rate in the early research of treating acute graft-versus-host disease (aGVHD). | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Socié G, et al. A phase 3 randomized trial comparing inolimomab vs usual care in steroid-resistant acute GVHD. Blood. 2017 Feb 2;129(5):643-649. [Content Brief]
- [2]. Piñana JL, et al. Encouraging results with inolimomab (anti-IL-2 receptor) as treatment for refractory acute graft-versus-host disease. Biol Blood Marrow Transplant. 2006 Nov;12(11):1135-41. [Content Brief]
